2026-10-27
In biopharmaceutical upstream R&D and technology transfer, Data Integrity represents a cornerstone requirement for complying with GXP (GMP/GLP) standards and FDA 21 CFR Part 11 regulations. Throughout a fermentation run, time-series data covering temperature, pH, dissolved oxygen (DO), cumulative dosing weights, and system alarm logs constitute critical quality records for drug development and regulatory filings.
Legacy fermentation control software that lacks robust data persistence and access control features introduces severe regulatory risks, including unrecorded process gaps, file tampering, and untraceable batch histories. When bioprocess engineers need to assemble comprehensive data packages for scale-up modeling or regulatory submission, missing or non-compliant records can delay project timelines and invalidate costly developmental batches. Consequently, evaluating data logging density, storage security, and user privilege isolation has become a paramount benchmark in bioreactor selection.
Modern automated bioreactor control software embeds high-frequency data persistence, multi-tier user privilege management, and multi-dimensional batch tracking directly into the controller architecture:
When selecting laboratory benchtop bioreactors for biopharmaceutical R&D and scale-up validation, bioprocess engineers and Quality Assurance (QA) teams should evaluate the following software specifications:
Send your inquiry directly to us